Loading clinical trials...
Loading clinical trials...
CD19-targeting Chimeric Antigen Receptor T-cell Therapy for Patients with Refractory and Relapsed B-cell Acute Lymphoblastic Leukemia
Conditions
Interventions
CAR T-cell therapy
Locations
1
China
The Fisrt Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
Start Date
December 1, 2015
Primary Completion Date
August 30, 2024
Completion Date
December 31, 2025
Last Updated
October 24, 2024
NCT05292664
NCT05809284
Lead Sponsor
The First Affiliated Hospital of Soochow University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions